Matthew Gline - Director, 10%+ Owner at Arbutus Biopharma Corp

Issuer-level insider activity

Role
Director, 10%+ Owner
Issuer ticker
ABUS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Matthew Gline since 24 Aug 2025

Reported holdings for Matthew Gline in Arbutus Biopharma Corp

Form 4 holding Director, 10%+ Owner

Arbutus Biopharma Corp

Security class
Common Shares
Shares / value
38,847,462
Estimated value
$127,536,218
Report date
24 Feb 2025
Price
$3.28
Ownership
By Roivant Sciences Ltd.

Transaction history for Matthew Gline in Arbutus Biopharma Corp

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .